Abstract:Introduction: One-third of people with epilepsy continue to experience seizures despite treatment with existing anti-seizure medications (ASMs). The failure of modern ASMs to substantially improve epilepsy prognosis has been partly attributed to overreliance on acute rodent models in preclinical drug development as they do not adequately recapitulate the mechanisms of human epilepsy, are labor-intensive and unsuitable for high-throughput screening (HTS). There is an urgent need to find human-relevant HTS models in preclinical drug development to identify novel anti-seizure compounds. Objectives: This paper developed high-throughput preclinical screening models to identify new ASMs. Methods: 14 natural compounds (a-asarone, a-asarone, curcumin, vinpocetine, magnolol, ligustrazine, osthole, tanshinone IIA, piperine, gastrodin, quercetin, berberine, chrysin, schizandrin A and resveratrol) were assessed for their ability to suppress epileptiform activity as measured by multi-electrode arrays (MEA) in neural cultures derived from human induced pluripotent stem cells (iPSCs). In parallel, they were tested for anti-seizure effects in zebrafish and mouse models, which have been widely used in development of modern ASMs. The effects of the compounds in these models were compared. Two approved ASMs were used as positive controls. Results: Epileptiform activity could be induced in iPSCs-derived neurons following treatment with 4aminopyridine (4-AP) and inhibited by standard ASMs, carbamazepine, and phenytoin. Eight of the 14 natural compounds significantly inhibited the epileptiform activity in iPSCs-derived neurons. Among them, piperine, magnolol, a-asarone, and osthole showed significant anti-seizure effects both in zebrafish and mice. Comparative analysis showed that compounds ineffective in the iPSCs-derived neural model also showed no anti-seizure effects in the zebrafish or mouse models. Conclusion: Our findings support the use of iPSCs-derived human neurons for first-line high-throughput screening to identify compounds with anti-seizure properties and exclude ineffective compounds. Effective compounds may then be selected for animal evaluation before clinical testing. This integrated approach may improve the efficiency of developing novel ASMs. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Establishment of the epilepsy model in vitro based on optical release of caged-glutamate

Dynamical regulation of epileptiform discharges caused by abnormal astrocyte function with optogenetic stimulation

Examining the low-voltage fast seizure-onset and its response to optogenetic stimulation in a biophysical network model of the hippocampus

Altered Glutamate Metabolism Contributes to Antiepileptogenic Effects in the Progression from Focal Seizure to Generalized Seizure by Low-Frequency Stimulation in the Ventral Hippocampus

Transition and Propagation of Epilepsy in an Improved Epileptor Model Coupled with Astrocyte

Optogenetic Control of Thalamus As a Tool for Interrupting Penicillin Induced Seizures.

Modeling seizure networks in neuron-glia cultures using microelectrode arrays

Decoding Epileptic Seizures: Exploring In Vitro Approaches to Unravel Pathophysiology and Propel Future Therapeutic Breakthroughs

Influence of the Epileptiform Discharge Microenvironment on the Differentiation of Oligodendrocyte Precursor Cells.

Dynamic Transitions of Epilepsy Waveforms Induced by Astrocyte Dysfunction and Electrical Stimulation.

The Role of Extracellular Glutamate Homeostasis Dysregulated by Astrocyte in Epileptic Discharges: a Model Evidence

Comparison of Three Administration Modes for Establishing a Zebrafish Seizure Model Induced by N-Methyl-D-aspartic Acid.

Establishment of Animal Model of Refractory Epilepsy and Preliminary Study of the Effects of Vagus Nerve Stimulation on Electroencephalogram in This Model

The research of Rat's epileptic waves based on optogenetics

An Integrated in Vitro Human Ipscs-Derived Neuron and in Vivo Animal Approach for Preclinical Screening of Anti-Seizure Compounds.

On-Demand Seizures Facilitate Rapid Screening of Therapeutics for Epilepsy

Characterization of kindled VGAT‐Cre mice as a new animal model of temporal lobe epilepsy

Effect of Recurrent Epileptiform Discharges Induced by Magnesium-Free Treatment on Developing Cortical Neurons in Vitro

The Up-Regulation of Voltage-Gated Sodium Channels Subtypes Coincides with an Increased Sodium Current in Hippocampal Neuronal Culture Model

Astrocytic Kir4.1 channels and gap junctions account for spontaneous epileptic seizure

Dynamic modeling and closed-loop modulation for absence seizures caused by abnormal glutamate uptake from astrocytes